Does PIMECROLIMUS Cause Application site discolouration? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Application site discolouration have been filed in association with PIMECROLIMUS (Pimecrolimus). This represents 0.4% of all adverse event reports for PIMECROLIMUS.
5
Reports of Application site discolouration with PIMECROLIMUS
0.4%
of all PIMECROLIMUS reports
0
Deaths
2
Hospitalizations
How Dangerous Is Application site discolouration From PIMECROLIMUS?
Of the 5 reports, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Application site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMECROLIMUS. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PIMECROLIMUS Cause?
Drug ineffective (349)
Treatment failure (139)
Psoriasis (114)
Off label use (113)
Pruritus (94)
Erythema (89)
Product use in unapproved indication (86)
Rash (82)
Application site pain (72)
Therapeutic product effect incomplete (65)
What Other Drugs Cause Application site discolouration?
SUMATRIPTAN (684)
BUPRENORPHINE (208)
INGENOL MEBUTATE (115)
MECHLORETHAMINE (101)
ESTRADIOL (89)
NICOTINE (87)
MINOXIDIL (76)
SALICYLIC ACID (76)
BECAPLERMIN (74)
DICLOFENAC (67)
Which PIMECROLIMUS Alternatives Have Lower Application site discolouration Risk?
PIMECROLIMUS vs PIMOZIDE
PIMECROLIMUS vs PINAVERIUM
PIMECROLIMUS vs PINDOLOL
PIMECROLIMUS vs PIOGLITAZONE
PIMECROLIMUS vs PIPAMPERONE